Table 1. Association analysis of lncHCP5 expression and the clinicopathological features in 80 HCC patients.
| Characteristics | Case number | lncHCP5 | P-value | |
|
Low (n=40) |
High (n=40) |
|||
| Number | 80 | 40 | 40 | |
| Ages (years) | 0.4957 | |||
| < 65 years | 47 | 25 | 22 | |
| ≥ 65 years | 33 | 15 | 18 | |
| Gender | 0.1990 | |||
| Male | 61 | 33 | 28 | |
| Female | 19 | 7 | 12 | |
| AFP, μg/L | 0.4123 | |||
| <400 ng/ml | 17 | 7 | 10 | |
| ≥ 400 ng/ml | 63 | 33 | 30 | |
| Cirrhosis | 0.5762 | |||
| Absent | 16 | 9 | 7 | |
| Present | 64 | 31 | 33 | |
| Tumor size | 0.0008 | |||
| ≤ 5 cm | 32 | 23 | 9 | |
| > 5 cm | 48 | 17 | 33 | |
| Tumor number | 0.1305 | |||
| Single | 46 | 27 | 22 | |
| Multiple | 34 | 13 | 21 | |
| Vascular invasion | 0.0013 | |||
| Absent | 18 | 3 | 15 | |
| Present | 62 | 37 | 25 | |
| TNM stage | 0.0116 | |||
| I - II | 49 | 30 | 19 | |
| III-IV | 31 | 10 | 21 | |
| Edmondson | 0.0005 | |||
| I - II | 51 | 33 | 18 | |
| III + IV | 29 | 7 | 22 | |
| Capsular | ||||
| Present | 53 | 25 | 28 | 0.4781 |
| Absent | 27 | 15 | 12 | |
aTwo-sided chi-squared test.
The median expression level was used as the cut-off.